These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Highlighting crypt necrosis by using confocal laser endomicroscopy for the in vivo and real-time diagnosis of GI graft-versus-host disease. Hundorfean G; Agaimy A; Chiriac MT; Rösler W; Mackensen A; Siebler J; Neurath MF J Clin Oncol; 2012 Dec; 30(35):e368-9. PubMed ID: 23109705 [No Abstract] [Full Text] [Related]
4. Many faces of graft-versus-host disease. Peñas PF; Zaman S Australas J Dermatol; 2010 Feb; 51(1):1-10; quiz 11. PubMed ID: 20148830 [TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease: case report and review of literature. Jing X; Halat S; Meleg-Smith S J La State Med Soc; 2006; 158(1):20-4. PubMed ID: 16602481 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation. Choi SI; Lee EJ; Kang DO; Lee SY; In KH; Kim HK; Park S Korean J Intern Med; 2016 Nov; 31(6):1181-1183. PubMed ID: 26701227 [No Abstract] [Full Text] [Related]
8. Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature. Padmanabhan S; Battiwalla M; Hahn T; Ball D; Paplham P; Brown K; Segal BH; McCarthy P; Almyroudis NG Transpl Infect Dis; 2007 Jun; 9(2):148-52. PubMed ID: 17462002 [TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease. Bastos Oreiro M; Castilla-Llorente C; de la Guía AL; de Paz R; Van Domselaar M; Nieto J; Rodriguez A; Gallardo D; Canales M; Bone Marrow Transplant; 2012 Sep; 47(9):1241-2. PubMed ID: 22307017 [No Abstract] [Full Text] [Related]
10. Clinical update on graft-versus-host disease in children. Goddard DS; Horn BN; McCalmont TH; Cordoro KM Semin Cutan Med Surg; 2010 Jun; 29(2):92-105. PubMed ID: 20579598 [TBL] [Abstract][Full Text] [Related]
11. [Correlation of donor and recipient serum interleukin 2 and tumor necrosis factor alpha levels to acute graft-versus-host disease in hematopoietic stem cell transplantation]. Hua JY; Zhou XH; Pang Y; Huang RW Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):831-3. PubMed ID: 20423859 [TBL] [Abstract][Full Text] [Related]
12. Erythema multiforme-like presentation of chronic graft versus host disease. Doherty C; Ulitsky O; Petronic-Rosic V J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S127-8. PubMed ID: 19119127 [No Abstract] [Full Text] [Related]
14. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Remberger M Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922 [No Abstract] [Full Text] [Related]
15. Acquired ichthyosis as a manifestation of acute cutaneous graft-versus-host disease. Huang J; Pol-Rodriguez M; Silvers D; Garzon MC Pediatr Dermatol; 2007; 24(1):49-52. PubMed ID: 17300650 [TBL] [Abstract][Full Text] [Related]
16. Nail fold capillaroscopy differs widely between systemic sclerosis and chronic graft vs host disease of the skin. Aschwanden M; Halter JP; Walker UA; Staub D; Tichelli A; Daikeler T; Jaeger KA; Tyndall A Rheumatology (Oxford); 2011 Jun; 50(6):1168-9. PubMed ID: 21454306 [No Abstract] [Full Text] [Related]